Acute chest with hemoglobin 4: transfuse now, exchange if the lungs get worse
Young adult with HbSS (homozygous sickle cell anemia), new infiltrate, rising oxygen need on a Sunday evening. Hemoglobin 4.1. Apheresis is not available until morning. Give blood now, or wait for the exchange?
Acute chest syndrome: new infiltrate on chest imaging plus fever, chest pain, cough, tachypnea or hypoxemia in sickle cell disease. HbS: sickle hemoglobin, the patient's own. HbA: normal adult hemoglobin, from donor blood. Simple transfusion: add donor red cells. Red cell exchange: apheresis removes the patient's red cells and replaces them with donor cells, so HbS falls without raising viscosity.
Why simple transfusion is enough at hemoglobin 4: the dilution math
Starting at hemoglobin 4
Starting at hemoglobin 9
Low hemoglobin leaves room to dilute HbS by transfusion alone. A higher hemoglobin leaves no room: if that patient needs blood, it is an exchange.
Drawn to scale, 0 to 12 g/dL. Assumes HbSS with about 95% HbS and no ongoing hemolysis; on hydroxyurea HbS starts lower. HbSC or HbS beta-plus thalassemia often start near 10: little room, usually exchange.
Algorithm
What the studies show
| Study | Who | Finding | Number to remember |
|---|---|---|---|
| Vichinsky, N Engl J Med 2000 | 671 episodes in 538 patients, 30 centers | 13% needed mechanical ventilation and 3% died; transfusion improved oxygenation | 13%ventilated |
| National Heart, Lung, and Blood Institute (NHLBI) panel, Yawn, JAMA 2014 | US national guideline | Urgent exchange for rapid progression: saturation under 90% on oxygen, more distress, spreading infiltrates, hemoglobin falling despite transfusion | Strongrecommendation, low-quality evidence |
| American Society of Hematology (ASH) guideline, Chou, Blood Adv 2020 | Systematic review | Severe acute chest: suggests exchange over simple transfusion. Moderate: either is acceptable | Conditionalvery low certainty; 0 randomized trials |
Bottom line: the decision is clinical, not driven by trials. Severity and trajectory choose exchange; a low hemoglobin makes simple transfusion work. Vichinsky also shows acute chest alone lowers hemoglobin by less than 1 g/dL on average.
Where people slip
- Waiting for apheresis while the hemoglobin is 4. Transfuse now; the exchange can follow in the morning.
- Transfusing past 10. The US panel says do not go above 10 (the UK allows 11). Above that, viscosity rises faster than oxygen delivery. Check hemoglobin after each unit or two.
- Giving non-phenotyped blood. Matching at least for Rh (C, E) and Kell reduces the alloantibodies that cause the next topic.
Fill the tank to 10, and stop there. Exchange when the lungs get worse, or when there is no room in the tank.
Sources
Retrieved from PubMed and the ASH, NHLBI and British Society for Haematology (BSH) guidelines, read on Nov 16, 2026.
- Chou ST, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020. doi:10.1182/bloodadvances.2019001143
- Yawn BP, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 2014. doi:10.1001/jama.2014.10517
- Vichinsky EP, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000. doi:10.1056/NEJM200006223422502
- Howard J, et al. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol 2015. doi:10.1111/bjh.13348
Hemoglobin falling in sickle cell: give more blood, or stop giving it?
Transfused at another hospital 9 days ago for a pain crisis. Arrives with hemoglobin 4.1; two units bring it only to 5.4. Bilirubin and LDH (lactate dehydrogenase) high, direct antiglobulin test pending. The team asks for a third unit. Will it help, or make it worse?
Aplastic crisis: parvovirus B19 shuts down red cell production for about a week; hemolysis continues at its usual rate, so hemoglobin falls. Sequestration: red cells pooled in the spleen or liver. Delayed hemolytic transfusion reaction (DHTR): destruction of donor cells days after a transfusion, usually from a new alloantibody. Hyperhemolysis: the severe form, where the patient's own cells are destroyed too, so hemoglobin ends below where it was before the transfusion. HbA%: the share of donor hemoglobin on electrophoresis; it shows whether the transfused cells are surviving.
Read the hemoglobin on a timeline
Schematic. Ended below the dotted line after a transfusion? Not just the donor cells are dying: stop the blood. (Blue had no transfusion.)
Aplastic crisis
- Recent transfusion
- Usually none
- Reticulocytes
- Near zero, the key clue
- LDH, bilirubin
- At the patient's usual level
- Confirm
- Parvovirus B19 PCR and IgM
- Do
- Transfuse; droplet isolation
DHTR, hyperhemolysis
- Recent transfusion
- Yes, usually 5 to 10 days before, up to about 4 weeks
- HbA%
- Falling: donor cells are disappearing
- LDH, bilirubin
- Well above baseline, dark urine, new pain
- Reticulocytes
- Can be low too: does not rule it in or out
- Antibodies
- Often a new one, but the direct antiglobulin test can be negative
- Do
- Stop transfusing unless life-threatening
Algorithm
What the studies show
| Study | Who | Finding | Number to remember |
|---|---|---|---|
| Habibi, Am J Hematol 2016 | 99 DHTR episodes in 69 adults, France | Dark urine 94%, pain crisis 89%, acute chest 50%; median hemoglobin low point 5.5; antibody found in only 62%; more transfusion did not help or made it worse | 6%died; median onset day 9 |
| ASH guideline, Chou, Blood Adv 2020 | Systematic review | For hyperhemolysis: IVIg plus high-dose steroid first, eculizumab second | Very lowcertainty, conditional recommendation |
| Dumas, Blood 2016 | 3 adolescents and young adults with life-threatening DHTR | Eculizumab stopped hemolysis when steroid and IVIg were not enough | 3 patientsoff-label; 1 died of infection |
Bottom line: the transfusion history and the HbA% make the diagnosis. Reticulocytes do not.
Where people slip
- Calling it parvovirus because the reticulocytes are low. In hyperhemolysis they can be low too. Ask first: transfusion in the last 4 weeks?
- Reassured by a negative direct antiglobulin test. It is often negative in hyperhemolysis.
- Ordering the third unit without the HbA%. If the donor cells are disappearing, more blood feeds the fire.
- Checking only your own blood bank. Antibodies fade over time; the old one is in another hospital's record.
- Giving IVIg before drawing the antibody screen. IVIg can interfere with serologic testing; draw first.
Hemoglobin 4 in sickle cell? Think ASH (yes, like the society).
Sources
Retrieved from PubMed and the ASH and British Society for Haematology (BSH) guidelines, read on Nov 16, 2026.
- Chou ST, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020. doi:10.1182/bloodadvances.2019001143
- Habibi A, et al. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes. Am J Hematol 2016. doi:10.1002/ajh.24460
- Pirenne F, Yazdanbakhsh K. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood 2018. doi:10.1182/blood-2018-02-785964
- Dumas G, et al. Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients. Blood 2016. doi:10.1182/blood-2015-09-669770
- Danaee A, et al. Hyperhemolysis in patients with hemoglobinopathies: a single-center experience and review of the literature. Transfus Med Rev 2015. doi:10.1016/j.tmrv.2015.06.001